Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Breast Cancer

Free Subscription 10.09.2018 1 Ann Surg Oncol 5 BMC Cancer 2 Breast Cancer 7 Breast Cancer Res 3 Breast Cancer Res Treat 1 Cancer 1 Cancer Lett 3 Cancer Res 1 Cell 3 Clin Breast Cancer 2 Clin Cancer Res 1 Clin Exp Metastasis 1 Eur J Surg Oncol 1 Gene 3 Int J Cancer 1 Int J Radiat Oncol Biol Phys 1 J Clin Oncol 2 JAMA 1 Lancet Oncol 2 NPJ Breast Cancer 4 Oncogene 1 PLoS Med 4 PLoS One 2 Proc Natl Acad Sci U S A 2 Radiology 1 Radiother Oncol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Ann Surg Oncol

1. LAGENDIJK M, van Egdom LSE, van Veen FEE, Vos EL, et al
   Patient-Reported Outcome Measures May Add Value in Breast Cancer Surgery.
   Ann Surg Oncol. 2018 Sep 3. pii: 10.1245/s10434-018-6729.
   PubMed     Text format     Abstract available
   
   

   
   BMC Cancer

2. NIAZI MKK, Senaras C, Pennell M, Arole V, et al
   Relationship between the Ki67 index and its area based approximation in breast cancer.
   BMC Cancer. 2018;18:867.
   PubMed     Text format     Abstract available
   
   
3. FAJKA-BOJA R, Marton A, Toth A, Blazso P, et al
   Increased insulin-like growth factor 1 production by polyploid adipose stem cells promotes growth of breast cancer cells.
   BMC Cancer. 2018;18:872.
   PubMed     Text format     Abstract available
   
   
4. KIRKHAM AA, Paterson DI, Prado CM, Mackey JM, et al
   Rationale and design of the Caloric Restriction and Exercise protection from Anthracycline Toxic Effects (CREATE) study: a 3-arm parallel group phase II randomized controlled trial in early breast cancer.
   BMC Cancer. 2018;18:864.
   PubMed     Text format     Abstract available
   
   
5. DUIVON M, Perrier J, Joly F, Licaj I, et al
   Impact of breast cancer on prospective memory functioning assessed by virtual reality and influence of sleep quality and hormonal therapy: PROSOM-K study.
   BMC Cancer. 2018;18:866.
   PubMed     Text format     Abstract available
   
   
6. BROEDERS MJM, Allgood P, Duffy SW, Hofvind S, et al
   The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.
   BMC Cancer. 2018;18:860.
   PubMed     Text format     Abstract available
   
   

   
   Breast Cancer

7. ABU-KHALAF M, Muralikrishnan S, Hatzis C, Canchi D, et al
   Breast cancer patients with brain metastasis undergoing GKRS.
   Breast Cancer. 2018 Sep 4. pii: 10.1007/s12282-018-0903.
   PubMed     Text format     Abstract available
   
   
8. TALIMA S, Kaseem H, Kaseem N
   Chemotherapy and targeted therapy for breast cancer patients with hepatitis C virus infection.
   Breast Cancer. 2018 Sep 6. pii: 10.1007/s12282-018-0904.
   PubMed     Text format     Abstract available
   
   

   
   Breast Cancer Res

9. LEONTOVICH AA, Jalalirad M, Salisbury JL, Mills L, et al
   NOTCH3 expression is linked to breast cancer seeding and distant metastasis.
   Breast Cancer Res. 2018;20:105.
   PubMed     Text format     Abstract available
   
   
10. WU J, Li X, Teng X, Rubin DL, et al
    Magnetic resonance imaging and molecular features associated with tumor-infiltrating lymphocytes in breast cancer.
    Breast Cancer Res. 2018;20:101.
    PubMed     Text format     Abstract available
    
    
11. BUUS R, Yeo B, Brentnall AR, Klintman M, et al
    Novel 18-gene signature for predicting relapse in ER-positive, HER2-negative breast cancer.
    Breast Cancer Res. 2018;20:103.
    PubMed     Text format     Abstract available
    
    
12. DU T, Sikora MJ, Levine KM, Tasdemir N, et al
    Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer.
    Breast Cancer Res. 2018;20:106.
    PubMed     Text format     Abstract available
    
    
13. BOUSQUENAUD M, Fico F, Solinas G, Ruegg C, et al
    Obesity promotes the expansion of metastasis-initiating cells in breast cancer.
    Breast Cancer Res. 2018;20:104.
    PubMed     Text format     Abstract available
    
    
14. ROSATO RR, Davila-Gonzalez D, Choi DS, Qian W, et al
    Evaluation of anti-PD-1-based therapy against triple-negative breast cancer patient-derived xenograft tumors engrafted in humanized mouse models.
    Breast Cancer Res. 2018;20:108.
    PubMed     Text format     Abstract available
    
    
15. SCHOFFSKI P, Cresta S, Mayer IA, Wildiers H, et al
    A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer.
    Breast Cancer Res. 2018;20:109.
    PubMed     Text format     Abstract available
    
    

    
    Breast Cancer Res Treat

16. OZAWA PMM, Alkhilaiwi F, Cavalli IJ, Malheiros D, et al
    Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
    Breast Cancer Res Treat. 2018 Sep 1. pii: 10.1007/s10549-018-4925.
    PubMed     Text format     Abstract available
    
    
17. ALTUNDAG K
    Regular exercise might be associated with higher skeletal muscle volume, favorable prognostic factor in breast cancer patients.
    Breast Cancer Res Treat. 2018 Sep 3. pii: 10.1007/s10549-018-4949.
    PubMed     Text format    
    
    
18. FENTIMAN IS
    Surgical options for male breast cancer.
    Breast Cancer Res Treat. 2018 Sep 5. pii: 10.1007/s10549-018-4952.
    PubMed     Text format     Abstract available
    
    

    
    Cancer

19. GUO F, Kuo YF, Shih YCT, Giordano SH, et al
    Trends in Breast Cancer Mortality by Stage at Diagnosis Among Young Women in the United States.
    Cancer. 2018 Sep 6. doi: 10.1002/cncr.31638.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Lett

20. BARONE I, Vircillo V, Giordano C, Gelsomino L, et al
    Activation of Farnesoid X Receptor Impairs The Tumor-Promoting Function of Breast Cancer-Associated Fibroblasts.
    Cancer Lett. 2018 Aug 31. pii: S0304-3835(18)30544.
    PubMed     Text format     Abstract available
    
    

    
    Cancer Res

21. GAUDET MM, Gierach GL, Carter BD, Luo J, et al
    Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype.
    Cancer Res. 2018 Sep 5. pii: 0008-5472.CAN-18-0502.
    PubMed     Text format     Abstract available
    
    
22. 
    Retraction: Zerumbone Abolishes RANKL-Induced NF-kappaB Activation, Inhibits Osteoclastogenesis, and Suppresses Human Breast Cancer-Induced Bone Loss in Athymic Nude Mice.
    Cancer Res. 2018;78:5186.
    PubMed     Text format    
    
    
23. HUANG F, Shi Q, Li Y, Xu L, et al
    HER2/EGFR-AKT signaling switches TGF-beta from inhibiting cell proliferation to promoting cell migration in breast cancer.
    Cancer Res. 2018 Aug 31. pii: 0008-5472.CAN-18-0136.
    PubMed     Text format     Abstract available
    
    

    
    Cell

24. KEREN L, Bosse M, Marquez D, Angoshtari R, et al
    A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging.
    Cell. 2018;174:1373-1387.
    PubMed     Text format     Abstract available
    
    

    
    Clin Breast Cancer

25. JI G, Zhang C, Guan S, Yao X, et al
    Erlotinib for Progressive Brain and Leptomeningeal Metastases From HER2-positive Breast Cancer After Treatment Failure With Trastuzumab and Lapatinib: Experience and Review of Literature.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30384.
    PubMed     Text format    
    
    
26. STEARNS V, Brufsky AM, Verma S, Cotter MJ, et al
    Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer.
    Clin Breast Cancer. 2018 Jul 30. pii: S1526-8209(18)30306.
    PubMed     Text format     Abstract available
    
    
27. HE J, Gu Y, Zhang S
    Vitamin A and Breast Cancer Survival: A Systematic Review and Meta-analysis.
    Clin Breast Cancer. 2018 Aug 4. pii: S1526-8209(18)30305.
    PubMed     Text format     Abstract available
    
    

    
    Clin Cancer Res

28. HENDERSON MC, Silver M, Tran Q, Letsios EE, et al
    A Non-Invasive Blood-Based Combinatorial Proteomic Biomarker Assay to Detect Breast Cancer in Women over age 50 with BI-RADS 3, 4, or 5 Assessment.
    Clin Cancer Res. 2018 Sep 5. pii: 1078-0432.CCR-18-0843.
    PubMed     Text format     Abstract available
    
    
29. CHEN X, Low KH, Alexander A, Jiang Y, et al
    Cyclin E overexpression sensitizes triple negative breast cancer to Wee1 kinase Inhibition.
    Clin Cancer Res. 2018 Sep 4. pii: 1078-0432.CCR-18-1446.
    PubMed     Text format     Abstract available
    
    

    
    Clin Exp Metastasis

30. KIRN V, Strake L, Thangarajah F, Richters L, et al
    ESR1-promoter-methylation status in primary breast cancer and its corresponding metastases.
    Clin Exp Metastasis. 2018 Sep 1. pii: 10.1007/s10585-018-9935.
    PubMed     Text format     Abstract available
    
    

    
    Eur J Surg Oncol

31. DE FREITAS TB, Lopes de Barros Lima KM, de Andrade Carvalho H, de Azevedo Marques P, et al
    What a difference a clip makes! Analysis of boost volume definition in radiation therapy for conservative breast surgery.
    Eur J Surg Oncol. 2018;44:1312-1317.
    PubMed     Text format     Abstract available
    
    

    
    Gene

32. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    PubMed     Text format     Abstract available
    
    

    
    Int J Cancer

33. FARVID MS, Stern MC, Norat T, Sasazuki S, et al
    Consumption of red and processed meat and breast cancer incidence: a systematic review and meta-analysis of prospective studies.
    Int J Cancer. 2018 Sep 5. doi: 10.1002/ijc.31848.
    PubMed     Text format     Abstract available
    
    
34. JIN ML, Kim YW, Jin HL, Kang H, et al
    Aberrant expression of SETD1A promotes survival and migration of estrogen receptor alpha-positive breast cancer cells.
    Int J Cancer. 2018 Sep 7. doi: 10.1002/ijc.31853.
    PubMed     Text format     Abstract available
    
    
35. LI J, Wen WX, Eklund M, Kvist A, et al
    Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort.
    Int J Cancer. 2018 Sep 2. doi: 10.1002/ijc.31841.
    PubMed     Text format     Abstract available
    
    

    
    Int J Radiat Oncol Biol Phys

36. NATARAJAN B, Spiegel D, Nichols EM, Feigenberg S, et al
    Findings on Surveillance Imaging After Preoperative Partial Breast Irradiation for Early Stage Breast Cancer.
    Int J Radiat Oncol Biol Phys. 2018 Jun 5. pii: S0360-3016(18)30911.
    PubMed     Text format     Abstract available
    
    

    
    J Clin Oncol

37. BEAU AB, Andersen PK, Vejborg I, Lynge E, et al
    Limitations in the Effect of Screening on Breast Cancer Mortality.
    J Clin Oncol. 2018 Sep 4:JCO2018780270. doi: 10.1200/JCO.2018.78.0270.
    PubMed     Text format     Abstract available
    
    

    
    JAMA

38. GROSS AL, Blot WJ, Visvanathan K
    BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer.
    JAMA. 2018;320:597-598.
    PubMed     Text format    
    
    
39. LEE GK, Sheckter CC
    Breast Reconstruction Following Breast Cancer Treatment-2018.
    JAMA. 2018 Aug 31. pii: 2701789. doi: 10.1001/jama.2018.12190.
    PubMed     Text format    
    
    

    
    Lancet Oncol

40. PE M, Dorme L, Coens C, Basch E, et al
    Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
    Lancet Oncol. 2018;19:e459-e469.
    PubMed     Text format     Abstract available
    
    

    
    NPJ Breast Cancer

41. DISCHINGER PS, Tovar EA, Essenburg CJ, Madaj ZB, et al
    NF1 deficiency correlates with estrogen receptor signaling and diminished survival in breast cancer.
    NPJ Breast Cancer. 2018;4:29.
    PubMed     Text format     Abstract available
    
    
42. COUTURE HD, Williams LA, Geradts J, Nyante SJ, et al
    Image analysis with deep learning to predict breast cancer grade, ER status, histologic subtype, and intrinsic subtype.
    NPJ Breast Cancer. 2018;4:30.
    PubMed     Text format     Abstract available
    
    

    
    Oncogene

43. LIU Y, Long YH, Wang SQ, Zhang YY, et al
    JMJD6 regulates histone H2A.X phosphorylation and promotes autophagy in triple-negative breast cancer cells via a novel tyrosine kinase activity.
    Oncogene. 2018 Sep 5. pii: 10.1038/s41388-018-0466.
    PubMed     Text format     Abstract available
    
    
44. LI Y, Zhang H, Zhao Y, Wang C, et al
    A mandatory role of nuclear PAK4-LIFR axis in breast-to-bone metastasis of ERalpha-positive breast cancer cells.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0456.
    PubMed     Text format     Abstract available
    
    
45. GOTO H, Shimono Y, Funakoshi Y, Imamura Y, et al
    Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.
    Oncogene. 2018 Sep 3. pii: 10.1038/s41388-018-0477.
    PubMed     Text format     Abstract available
    
    
46. TRABOULSI T, El Ezzy M, Dumeaux V, Audemard E, et al
    Role of SUMOylation in differential ERalpha transcriptional repression by tamoxifen and fulvestrant in breast cancer cells.
    Oncogene. 2018 Sep 6. pii: 10.1038/s41388-018-0468.
    PubMed     Text format     Abstract available
    
    

    
    PLoS Med

47. ZHANG X, Rice M, Tworoger SS, Rosner BA, et al
    Addition of a polygenic risk score, mammographic density, and endogenous hormones to existing breast cancer risk prediction models: A nested case-control study.
    PLoS Med. 2018;15:e1002644.
    PubMed     Text format     Abstract available
    
    

    
    PLoS One

48. SCIOLI MG, Artuso S, D'Angelo C, Porru M, et al
    Adipose-derived stem cell-mediated paclitaxel delivery inhibits breast cancer growth.
    PLoS One. 2018;13:e0203426.
    PubMed     Text format     Abstract available
    
    
49. XU S, Thompson W, Kerr J, Godbole S, et al
    Modeling interrelationships between health behaviors in overweight breast cancer survivors: Applying Bayesian networks.
    PLoS One. 2018;13:e0202923.
    PubMed     Text format     Abstract available
    
    
50. MON AM, MacKinnon AC Jr, Traktman P
    Overexpression of the VRK1 kinase, which is associated with breast cancer, induces a mesenchymal to epithelial transition in mammary epithelial cells.
    PLoS One. 2018;13:e0203397.
    PubMed     Text format     Abstract available
    
    
51. TAMAYO LI, Vidaurre T, Navarro Vasquez J, Casavilca S, et al
    Breast cancer subtype and survival among Indigenous American women in Peru.
    PLoS One. 2018;13:e0201287.
    PubMed     Text format     Abstract available
    
    

    
    Proc Natl Acad Sci U S A

52. SEO A, Steinberg-Shemer O, Unal S, Casadei S, et al
    Mechanism for survival of homozygous nonsense mutations in the tumor suppressor gene BRCA1.
    Proc Natl Acad Sci U S A. 2018;115:5241-5246.
    PubMed     Text format     Abstract available
    
    
53. LEE JJ, van de Ven RAH, Zaganjor E, Ng MR, et al
    Inhibition of epithelial cell migration and Src/FAK signaling by SIRT3.
    Proc Natl Acad Sci U S A. 2018;115:7057-7062.
    PubMed     Text format     Abstract available
    
    

    
    Radiology

54. DESOUZA NM
    Diffusion-weighted MRI in Multicenter Trials of Breast Cancer: A Useful Measure of Tumor Response?
    Radiology. 2018 Sep 4:181717. doi: 10.1148/radiol.2018181717.
    PubMed     Text format    
    
    
55. PARTRIDGE SC, Zhang Z, Newitt DC, Gibbs JE, et al
    Diffusion-weighted MRI Findings Predict Pathologic Response in Neoadjuvant Treatment of Breast Cancer: The ACRIN 6698 Multicenter Trial.
    Radiology. 2018 Sep 4:180273. doi: 10.1148/radiol.2018180273.
    PubMed     Text format     Abstract available
    
    

    
    Radiother Oncol

56. LISSIDINI G, Trifiro G, Veronesi P, Grana C, et al
    Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?
    Radiother Oncol. 2018 Aug 30. pii: S0167-8140(18)33439.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: